21 – 30 of 2269
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers Apoptosis
- Contribution to journal › Article
-
Mark
Second- and Third-Line Salvage Chemotherapy Followed by Allogeneic Stem Cell Transplantation Leads to High Survival Rates in Primary Refractory AML—A Population-Based Study
- Contribution to journal › Article
-
Mark
Validation of Guidelines for Genetic Investigation of Myeloid Neoplasms with Germline Predisposition : Results from a Prospective Cohort Study
- Contribution to journal › Article
-
Mark
Peripheral T- and natural killer-cell lymphomas : ESMO–EHA Clinical Practice Guideline for diagnosis, treatment and follow-up ☆
- Contribution to journal › Article
-
Mark
The Swedish Society of Paediatric Infectious Diseases' 2025 Recommendations for the Initial Management of Suspected Paediatric Sepsis With or Without Shock
(2025) In Acta Pædiatrica
- Contribution to journal › Scientific review
-
Mark
Proteomic Profiling of Acoustically Isolated Extracellular Vesicles from Blood Plasma during Murine Bacterial Sepsis
- Contribution to journal › Article
-
Mark
iPSCs unlock clues to pediatric AML onset
- Contribution to journal › Debate/Note/Editorial
-
Mark
Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)
- Contribution to journal › Article
-
Mark
Hemophilia B Leyden : characteristics and natural history in the International Pediatric Network of Hemophilia Management Registry
- Contribution to journal › Article
-
Mark
Limited stage mantle cell lymphoma : A real-world study of primary treatment and prognosis in Sweden 2006–2018
- Contribution to journal › Letter
